gip-1 vs glp-1 Two incretin hormones and GIP: Comparison of their actions in insulin secretion and β cell preservation Dual GLP-1/GIP Agonist | Tirzepatide

The GLP-1 receptor agonist market size was exhibited at USD 36.95 billion in 2023 and is projected to hit around USD 261.19 billion by 2033, growing at a CAGR of 21.6% during the forecast period 2024 to 2033.

Please consult a healthcare professional before using any dietary supplement, especially if you are pregnant, nursing, taking medication, or have a medical condition

No side effects

Learn how to manage diarrhoea from GLP-1 injections

The growing popularity of GLP-1 weight-loss drugs is reshaping the yogurt market, as consumers increasingly seek protein-packed snacks.

Built for people who eat less not a generic multivitamin